Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Must-Buy Growth Stocks for Your January Buy List

By Josh Enomoto, InvestorPlace Contributor

With a new year on the books, risk-tolerant contrarian investors may want to try their hands on these growth stocks to buy.

7 Must-Buy Penny Stocks for Your January Buy List

By Josh Enomoto, InvestorPlace Contributor

If you want to gamble and can handle the likely volatility risks, these penny stocks to buy could boost your portfolio in January.

7 Stocks Under $50 to Buy and Hold Forever

By Josh Enomoto, InvestorPlace Contributor

Long-term investors looking to get positioned in 2023 should consider these stocks under $50 to buy and hold.

What Roku’s New TV Line Means for ROKU Stock

By Josh Enomoto, InvestorPlace Contributor

Although Roku announced a new in-house TV manufacturing initiative, the forward-looking narrative for ROKU stock remains challenging.

Why Is Geron (GERN) Stock Soaring 50% Today?

By Josh Enomoto, InvestorPlace Contributor

Late-stage clinical biopharma Geron delivered positive results for its blood cancer therapeutic, dramatically lifting GERN stock.

Load More